Strategy Update

AI SummaryClose X

Physiomics plc has announced a strategy update focusing on operational optimisation, commercial execution, and shareholder value creation, with the new Board initiating a comprehensive business review. The company believes it has underappreciated strengths including its scientific platform and commercial pipeline, and is implementing disciplined capital allocation and cost control measures. New Directors will receive part of their remuneration in ordinary shares, with the aggregate cash cost of Board remuneration and the finance function expected to remain unchanged. The company's cash runway is assessed to extend into 2027, and the Board sees significant opportunities for operational enhancement and commercial improvement. Physiomics has also confirmed no payments were made to former personnel outside of contractual entitlements.

Disclaimer*

Companies

Physiomics (PYC)
UK 100

Latest directors dealings